PTGS2 and carcinoma: In comparison with our data, where over-expression in 77% of colorectal carcinomas is noticed, this suggests that over-expression of COX-2 is lower in colorectal adenomas than in carcinomas, and that expression is increasing somewhere in the stage between adenoma and carcinoma.